Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer
Clinical trial NCT00433095 · COMPLETED
Trial details
- NCT number
- NCT00433095
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.